Elimination of High-grade Gliomas Through Induced Cytolysis, Elucidated by Two Patient Cases
This innovative approach not only enhances local drug delivery but also minimizes systemic side effects, addressing a critical challenge in GBM treatment. These cases highlight the potential of this protocol as an adjunct to standard therapies, offering a promising option for managing inoperable or recurrent GBM.
Authors
- Christos Panotopoulos
- George Panayotou (ORCID: https://orcid.org/0009-0009-9538-1638)
- George S. Athanasiou (ORCID: https://orcid.org/0000-0002-3221-7189)
- Gunnar Ronquist
- S. William Stavropoulos
- N. K. Venkataramana
- SHAILESH AV RAO
- NICK BOUTOS
Institutions
- Uppsala University (SE)
- St. John's National Academy of Health Sciences (IN)
- MediHope Super Specialty Hospital (IN)
- Alexander Fleming Biomedical Sciences Research Center (GR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-30
- DOI
- https://doi.org/10.21873/anticanres.17405
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00